Zuchner and colleagues identified that CDKN2A at 9p21 are implicated in the susceptibility in the late-onset AD (Zuchner et al., 2008), but the role of CDKN2A genetic variants in AD is not confirmed in late-onset patients based on Tedde and colleagues's (2011). This evidence concerns the gene CDKN2A and Alzheimer disease.